The African Centre for Biodiversity (ACB) welcomes you to our website. We are a research and advocacy organisation working towards food sovereignty and agro-ecology in Africa, with a focus on biosafety, seed systems and agricultural biodiversity. The organisation is committed to dismantling inequalities and resisting corporate-industrial expansion in Africa's food and agriculture systems.
The African Centre for Biodiversity (ACB) has made a submission to the Registrar of GMOs in South Africa, following an application made by Professor Shabir Ahmed Madhi, from the Respiratory and Meningeal Pathogens Research Unit (RMPRU), Chris Hani Baragwanath Academic Hospital, for approval for release of ChAdOx1 nCo-V-19, a genetically modified (GM) vaccine, for clinical phase I/II trials on 2 800 both healthy and HIV-positive adults over a period of 12 months.
Human health and wellbeing at great risk unless biodiversity and genetic resources extraction in Africa is halted
“We need more genetic diversity, not less, and we need to vigorously defend genetic diversity as a common good, not something that can be extracted and privately profited from.”
The ACB has collaborated with the Regional Network for Equity in Health in East and Southern Africa (EQUINET), and produced a report that is calling for an urgent halt to the wanton extraction and exploitation of the genetic diversity of plants, animals and forests in East and Southern Africa. They argue that these resources are declining at alarming rates, and thereby putting the ecological systems and the health and wellbeing of populations in the region at great risk.